Skip 
Navigation Link
Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
Health Tip: Identifying Chicken PoxCould Pests, Dust Lower Kids' Odds for Asthma?When a Cold or Flu Strikes a Family MemberBooze Often Glorified On YouTube VideosInflammatory Bowel Disease May Raise Cancer Risk in KidsKids' Colds Linked to Asthma, Lung Problems LaterAAP: Few Doctors Provide Firearm Injury Prevention Info in ERDoctors Eye the Danger From 'Nerf' GunsParents Say Schools Don't Help Kids With Mental Health, Chronic DiseaseIt's a Food Allergy! Where's the School Nurse?Big Rise in Hospitalized Kids With Opioid Side EffectsAAP: Opioid Dependence/Abuse Public Health Issue for ChildrenGolf Carts' Use Is Spreading, and So Is Danger to KidsState Laws Have Big Impact on Kids' Gun InjuriesHealth Tip: On Kids and Pets'Microbiomes' May Hold Key to Kids' Ear InfectionsHurricanes May Have Longer-Lasting Impact on KidsHeath Tip: Getting Rid of Head LiceState Laws Curb Kids' Injuries Tied to Off-Road VehiclesBrown-Bagging It? Think Outside the BoxVaccine Campaign in Poor Countries to Save 20 Million LivesGuinea Pigs Harbor a Hidden Health HazardFor City Kids With Asthma, Nearby Green Space Is KeyEarly Respiratory Infections Tied to Celiac in High-Risk ChildrenHealth Tip: Fuel Your Child With a Good BreakfastIncrease in Medical Exemptions From Immunization in CaliforniaPut Flu Shot on the Back-to-School ChecklistSmoking Bans Help Kids Breathe EasierThroat Bacteria Linked to Bone and Joint Infection in KidsHarvey's Wrath Still Poses Risks to ChildrenHeath Tip: It's Back-to-School TimeHelping Kids Adapt to a New SchoolWhite Kids More Likely to Get Unneeded AntibioticsBack to School, Back to Planning for Kids With Autism, ADHDTake the Back Pain Out of BackpacksChild Flu Vaccination Down When Nasal Spray UnavailableNasal Flu Vaccine's Demise May Mean Fewer Immunized KidsHealth Tip: Identify BullyingHealth Tip: Prepare for Your Child's Dental ProcedureIntracranial Pressure Monitoring No Benefit in Pediatric TBIFDA Approves 1st Treatment for 'Kissing Bug' Illness in ChildrenMany Parents Don't Tell Doctor About 'Complementary' Therapy Use in KidsHealth Tip: Back to School for Kids with AsthmaVaccination 101: Make Sure Kids Are Up to DateSerious Reactions to Vaccines Rarely Recur: ReviewParents Worried About Cyberbullies as School Starts UpCookies, Apples or Yogurt? Not Always a Simple Choice for KidsCyberbullying Weighs Heavily on Young PeopleHaving Same-Sex Parents Won't Affect Kids' Gender Identity: StudyKids' Cases of High Blood Pressure May Rise Under New Guidelines
Questions and AnswersLinksBook Reviews
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Parenting
Child Development & Parenting: Infants (0-2)
Child Development & Parenting: Early (3-7)

Researchers Target Zolmitriptan Dosing for Pediatric Migraine


HealthDay News
Updated: Jun 8th 2017

new article illustration

THURSDAY, June 8, 2017 (HealthDay News) -- In a report published online June 5 in the Journal of Clinical Pharmacology, recommended dosing regimens of zolmitriptan are suggested for children with migraine.

Wangda Zhou, Ph.D., from AstraZeneca Pharmaceuticals in Waltham, Mass., and colleagues developed a population pharmacokinetic model for zolmitriptan and its active metabolite in adults and adolescents, and provided appropriate dosing regimens for use in clinical trials in 6- to 11-year-old children. Data from a single-dose study involving 5.0-mg zolmitriptan nasal spray (ZNS) conducted in adult and adolescents with migraine were applied.

The researchers found that adults and adolescents had similar plasma concentration profiles of zolmitriptan and its metabolite 183C91. The estimated typical apparent volume of distribution and clearance of zolmitriptan were 136 L and 121 L/h, respectively; between-subject variability was 56.5 and 42.6 percent, respectively. To achieve exposures similar to those of the adult and adolescent population administered 5.0 mg ZNS, a body-weight dosing scheme of 5.0 and 2.5 mg ZNS is recommended in children greater than and less than 50 kg, respectively.

"The recommended doses for children to achieve exposure similar to that observed in adults given 2.5 mg ZNS are 2.5 mg (≥50 kg) and 1.0 mg (15 to 50 kg)," the authors write. "These dosing regimens could be used in future clinical trials."

The authors disclosed financial ties to AstraZeneca, a manufacturer of zolmitriptan.

Abstract
Full Text (subscription or payment may be required)